Cynosure (CYNO) Misses Q4 EPS by 3c

Cynosure (NASDAQ: CYNO) reported Q4 EPS of $0.36, $0.03 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $86.3 million versus the consensus estimate of $83.01 million.

For earnings history and earnings-related data on Cynosure (CYNO) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Yeti Holdings Inc. (YETI) PT Raised to $45 at Stifel on Beat and Raise Q2 Results